Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer.
Saved in:
| Title: | Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer. |
|---|---|
| Authors: | Lee HJ Jr; Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA 94143, United States., Boscardin J; Division of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Health Care System, San Francisco, CA 94143, United States., Walter LC; Division of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Health Care System, San Francisco, CA 94143, United States., Smith AK; Division of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Health Care System, San Francisco, CA 94143, United States., Cohen HJ; Center for the Study of Aging & Human Development and Duke Cancer Institute, Duke University, Durham, NC 27708, United States., Giri S; Divisions of Hematology/Oncology and Gerontology, Geriatrics, and Palliative Care, The University of Alabama at Birmingham, Birmingham, AL 35294, United States., Williams GR; Divisions of Hematology/Oncology and Gerontology, Geriatrics, and Palliative Care, The University of Alabama at Birmingham, Birmingham, AL 35294, United States., Presley CJ; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, United States., Singhal S; Division of Hematology and Oncology, University of California, Davis, Sacramento, CA 95819, United States., Huang LW; Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA 94143, United States.; Division of Hematology-Oncology, San Francisco Veterans Affairs Health Care System, San Francisco, CA 94121, United States., Velazquez AI; Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. San Francisco, CA 94143, United States., Gubens MA; Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. San Francisco, CA 94143, United States., Blakely CM; Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. San Francisco, CA 94143, United States., Mulvey CK; Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. San Francisco, CA 94143, United States., Cheng ML; Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. San Francisco, CA 94143, United States., Sakoda LC; Division of Research, Kaiser Permanente Northern California, The Permanente Medical Group, Pleasanton, CA 94588, United States.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA 91101, United States., Kushi LH; Division of Research, Kaiser Permanente Northern California, The Permanente Medical Group, Pleasanton, CA 94588, United States., Quesenberry C; Division of Research, Kaiser Permanente Northern California, The Permanente Medical Group, Pleasanton, CA 94588, United States., Liu R; Division of Research, Kaiser Permanente Northern California, The Permanente Medical Group, Pleasanton, CA 94588, United States.; Division of Hematology-Oncology, Kaiser Permanente San Francisco Medical Center, The Permanente Medical Group, San Francisco, CA 94115, United States., Fleszar-Pavlovic S; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States., Eskandar C; Division of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Health Care System, San Francisco, CA 94143, United States., Cutler E; Lens Study Patient and Caregiver Advisory Board, Pleasanton, CA 94588, United States., Mercurio AM; Lens Study Patient and Caregiver Advisory Board, Pleasanton, CA 94588, United States., Wong ML; Division of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Health Care System, San Francisco, CA 94143, United States.; Division of Research, Kaiser Permanente Northern California, The Permanente Medical Group, Pleasanton, CA 94588, United States.; Division of Hematology-Oncology, Kaiser Permanente San Francisco Medical Center, The Permanente Medical Group, San Francisco, CA 94115, United States. |
| Source: | The oncologist [Oncologist] 2025 Aug 04; Vol. 30 (8). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyae349 |
